Media

The more we know, the more we achieve.

Videos, podcasts, press releases – all here to help us grow what we know.

Beta Bionics.
Made with humanity.

Our media.

Beta Bionics Appoints Sean Saint as CEO and Board Member

Caution: The iLet® Bionic Pancreas and iLet Duo™ are investigational…

Pivotal Trial Results of the iLet® Bionic Pancreas to Be Presented at the ADA’s 82nd Scientific Sessions

Caution: The iLet® Bionic Pancreas is an investigational device…

Beta Bionics Appoints Gilad Glick to the Board of Directors and Veena Rao, Ph.D. as Chief Commercial Officer

Caution: The iLet® Bionic Pancreas is an investigational device…

Pivotal Trial Results of the iLet® Bionic Pancreas To Be Presented at ATTD

Caution: The iLet® Bionic Pancreas is an investigational device…

Beta Bionics Announces Closing of $57 Million Series C Financing

Caution: The iLet® Bionic Pancreas is an investigational device…

Beta Bionics Announces Appointment of Christy Jones to Board of Directors

Irvine, CA – May 6, 2021 – Beta Bionics, Inc., a medical…
xlargeWebP_family_03_hero_f43a45fd1d

Beta Bionics announces the appointment of Martha Goldberg Aronson as Chair of its Board of Directors

Concord, MA – February 9, 2021 – Beta Bionics, Inc., a medical…
xlargeWebP_family_05_hero_76618d7210

Beta Bionics appoints Beth Brooke to its Board as Independent Director

Concord, MA – December 30, 2020 – Beta Bionics, Inc. —…
xlargeWebP_family_02_hero_2efa21a516

Beta Bionics appoints Martha Aronson and Sean Carney to its Board as Independent Directors

West Concord, MA – February 20, 2020 – Beta Bionics, Inc.…
xlargeWebP_adolescent_01_hero_62f03a579a

Beta Bionics receives FDA breakthrough device designation for the iLet™ Bionic Pancreas System

The iLet is a pocket-sized, wearable investigational medical…
xlargeWebP_senior_04_hero_6e2d9ee7da
xlargeWebP_family_09_hero_cf30f9d055
xlargeWebP_family_06_hero_742403d9ff
xlargeWebP_family_08_hero_7f96dc901f

Beta Bionics Announces Final Closing of Its $63 Million Series B Financing

New investors include ArrowMark, LifeSci Venture Partners,…

Beta Bionics awarded up to $2 million NIH small business innovation research (SBIR) grant

Award from the National Institute of Diabetes and Digestive…

Beta Bionics secures an initial $50 million Series B round

The round was led by Eventide Asset Management Other institutional…
xlargeWebP_senior_02_hero_fb88c6bf7f
xlargeWebP_senior_01_hero_2e17d1718f

Zealand Pharma boosts collaboration with Beta Bionics to advance development of its dasiglucagon in the iLet™

Zealand Pharma makes an initial USD 1.5 million equity investment…

Phase 2a trial results support development of dasiglucagon in the iLet™ pump system for type 1 diabetes

Dasiglucagon* is a potential first-in-class glucagon analog…
xlargeWebP_adolescent_07_hero_39c584dbbe